Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Aptensio XR
  2. Concerta
  3. Cotempla XR-ODT
  4. Jornay PM
  5. Metadate ER
  6. Methylin
  7. Methylin ER
  8. QuilliChew ER
  9. Quillivant XR
  10. Ritalin
  11. Ritalin LA
  12. Ritalin-SR

Descriptions


Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central nervous system (CNS) stimulants.

Methylphenidate is also used to treat narcolepsy. Narcolepsy is an uncontrollable desire for sleep or a sudden attack of deep sleep.

Methylphenidate works in the treatment of ADHD by increasing attention and decreasing restlessness in children and adults who are overactive, cannot concentrate for very long, or are easily distracted and impulsive. This medicine is used as part of a total treatment program that also includes social, educational, and psychological treatment.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet, Extended Release, Disintegrating
  • Capsule, Extended Release Biphasic 40/60
  • Capsule, Extended Release Biphasic 30/70
  • Tablet, Chewable
  • Capsule, Extended Release
  • Tablet, Extended Release
  • Solution
  • Capsule, Extended Release Biphasic 50/50
  • Tablet
  • Powder for Suspension, Extended Release
  • Tablet, Extended Release, Chewable

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Portions of this document last updated: April 01, 2024

Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.